RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add-on to sodium-glucose co-transporter-2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes.

Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add-on to sodium-glucose co-transporter-2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes.

Add to Collection
2019 Jun RCTs Fist_Author_Year_PM

Full Author : ['Philis-Tsimikas, Athena', 'Billings, Liana K', 'Busch, Robert', 'Portillo, Cristobal Morales', 'Sahay, Rakesh', 'Halladin, Natalie', 'Eggert, Sarah', 'Begtrup, Kamilla', 'Harris, Stewart']
Journal Title : Diabetes, obesity & metabolism
Chapter : Section3
Journal Year : 2019
Cited by : Not Available

AIM: To investigate the efficacy and safety of insulin degludec/liraglutide (IDegLira) versus insulin glargine 100 units/mL (IGlar U100) as add-on to sodium-glucose co-transporter-2 (SGLT2) inhibitor therapy. MATERIALS AND METHODS: In this 26-week, phase .....

Keywords : ["insulin degludecliraglutide versus insulin glargine", "uncontrolled type diabetes", "sodiumglucose inhibitor therapy", "randomized clinical trial", "superior efficacy", "people", "addon"]